Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12684875Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$3M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#3,421
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Christian Harding as a PI. Multi-PI records show the full award amount for context.
- 2R44AI167078-03A1R44A capsule-based bioconjugate vaccine to prevent Klebsiella pneumoniae infections$1Maward amount
- 5R42AI165116-04R42A multivalent O-antigen bioconjugate vaccine for the prevention of Klebsiella pneumoniae infections$999.7Kaward amount
- $995.7Kaward amount
Award organization
Organizations that administered FY2025 awards listing Christian Harding as a PI.
FY2025 award administered by Vaxnewmo, Llc (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardVaxnewmo, Llc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5406
- 2025$2M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #3421